Company Valuation: CS Diagnostics Corp.

Data adjusted to current consolidation scope
Fiscal Period: December 2023 2024 2025
Market Cap 1 0.3951 150.6 76.47
Change - 38,005.96% -49.21%
Enterprise Value (EV) 1 0.3747 150.6 76.47
Change - 40,076.48% -49.21%
P/E -2,525x 232,000x 1,077x
PBR 0.11x 0.32x 0.15x
PEG - -2,263x 0x
Capitalization / Revenue 3.13x 1,357x 375x
EV / Revenue 2.97x 1,357x 375x
EV / EBITDA - - -
EV / EBIT -17x 197,840x 1,074x
EV / FCF - - -
FCF Yield - - -
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 -0.000198 0.000005 0.000284
Distribution rate - - -
Net sales 1 0.126 0.1109 0.204
EBITDA - - -
EBIT 1 -0.022 0.000761 0.0712
Net income 1 -0.022 0.000761 0.0712
Net Debt 1 -0.0204 -0.000501 -0.006813
Reference price 2 0.500000 1.160000 0.305900
Nbr of stocks (in thousands) 790 129,790 249,992
Announcement Date 7/29/25 7/29/25 4/15/26
1USD in Million2USD
Estimates


P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 1.82M
33.95x4.03x15.12x2.53% 178B
23.66x4.63x16.25x1.18% 117B
20.38x3.52x12.6x2.99% 116B
31.19x3.01x12.15x2.29% 91.03B
17.79x0.21x12.9x0.73% 61.89B
31.8x7.97x20.49x1.24% 55.85B
38.71x3.58x12.19x2.14% 53.16B
38.13x9.47x26.48x-.--% 44.35B
40.31x3.26x12.12x0.53% 33.59B
Average 30.66x 4.41x 15.59x 1.52% 75.01B
Weighted average by Cap. 29.29x 4.15x 15.09x 1.85%

Y-o-Y evolution of P/E

Valuation ratios - P/E - CS Diagnostics Corp.

Historical PBR trend

Valuation ratios - PBR - CS Diagnostics Corp.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - CS Diagnostics Corp.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - CS Diagnostics Corp.

  1. Stock Market
  2. Stocks
  3. CSDX Stock
  4. Valuation CS Diagnostics Corp.